An insider at United Therapeutics sold shares for about $1,171,609, according to a recent SEC filing.

Nov 6, 2026, 6:48 PM ETPaperworkRead the original at marketscreener.com

Neutral

A filing reports an insider share sale worth about $1.2 million, but gives no sign of a change in United Therapeutics' business. It does not change the company's outlook.

UTHR · United Therapeutics Corporation

AI read · Neutral

The AI's read

An insider's personal share sale does not show whether United Therapeutics is selling more medicines or earning more profit. The filing gives no business results or reason for the sale, so it offers no clear sign of a change in the company's outlook.

Get alerts for UTHR

Follow United Therapeutics Corporation (UTHR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for UTHR

Free on the App Store and Google Play, or on the web.